Candidates for the assignment as Academic Vice President for the Committee of Research

KI's Nomination Assembly has appointed candidates for the election of new academic vice presidents to KI's committees.

Updates on the page

Open hearing with the candidates for vice president for the Committee of Research

A recording from the hearing with candidates for the assignment as Academic Vice President for the Committee of Research is now available on the page. Marie Arsenian-Henriksson, Martin Bergö, Christian Giske and Catharina Larsson make presentations and share their visions and personal achievements. Christian Giske, who speaks in English, starts at 23.59.

See the recorded hearing here

The Committee for Research (KF) provides support to the Faculty Board by means of preparation, quality control and implementation regarding research. KF works strategically with research issues by making special investments, as well as organising and being responsible for the activities of its sub-bodies. KF is also responsible for research infrastructure, center establishing etc.

The new term of office for the duties of the vice presidents is from 1 January 2023 to 31 December 2025.

The following candidates have been appointed to the committee for first and second-cycle levels:

Marie Arsenian-Henriksson
Marie Arsenian-Henriksson, Professor at MTC Photo: Private

Marie Arsenian-Henriksson, Professor at MTC

About me:

My research group studies basic mechanisms that result in the incidence of cancer and our aim is to develop innovative cancer therapies. After my period as head of department, I spent six months researching at FHCRC (Fred Hutch), Seattle, USA. I have a number of national and international assignments and collaborations. Fourteen doctoral students have publicly defended their doctoral theses with me as their supervisor (eight as the principal supervisor). I have also supervised 25 postdocs and I am currently the principal supervisor for three doctoral students, co-supervisor for four, and I am supervising four postdocs and four students. I publicly defended my doctoral thesis at KI with a thesis on the function of the MYC protein and then I completed a postdoc in Germany. Since then, I have built up my research activities on the childhood cancer neuroblastoma.

Marie Arsenian-Henriksson's profile page.

Visions for my assignment:

  • The research should be carried out with an innovative perspective in order to facilitate fundamental discoveries and research breakthroughs.
  • KI should be guided by a common vision of academic excellence and should be an internationally leading university that attracts students and researchers from all over the world.
  • A future KI should have an open-minded atmosphere and students and employees should be able to thrive, be challenged and develop to reach their full potential.
  • Recruitment and career. Future opportunities are important, young people should be able to understand what they need for a future at KI. Transparency and clear career paths are fundamental. KI must retain creative researchers and excellent teachers and recruit a new generation of professors.
  • Conditions for research. Allocation of resources, co-financing and INDI (indirect costs) need to be examined. Both large and small research groups must be given the opportunity to carry out record-breaking research.
  • We need to strengthen collaboration with the hospital and healthcare sector, surrounding universities (KTH Royal Institute of Technology, Stockholm University, Stockholm School of Economics, and Uppsala University) and the business community. KI should continue to take the lead and be active during the current and future pandemics.
Portrait of Martin Bergö
Martin Bergö, Professor at BioNut Photo: Ulf Sirborn

Martin Bergö, Professor at BioNut

About me:

With research as my goal, I studied chemistry and medicine in Umeå in the 1990s, and carried out doctoral research in parallel with medical school. After a long postdoc in the USA, I started my own group in Gothenburg in 2005 and came to Karolinska Institutet in 2015 via an offer of professorship. With good funding, positions and awards to my name - and support from mentors - I have had the privilege of being able to carry out curiosity-oriented research with the resources to change research field when our data led us in new directions: we are now studying the importance of antioxidants and oxidative stress in cancer using basic scientific and translational techniques. Colleagues usually appreciate my interest and engagement in their research, careers and challenges. For my part, I value my resistance to stress and that I take pleasure in all parts of my work, from discussing hypotheses and results with doctoral students to leading board meetings, interacting with Junior Faculty, working in the Nobel Assembly and lecturing for patient organisations and politicians.

Martin Bergö's profile page.

Visions for my assignment:

KI is a top-ranked university but faces major challenges. My visions to meet these challenges are as follows:

  • Channel the collective will and wealth of ideas in the activities to make KI's research even better.
  • Continuously inform the outside world and politicians about the need to pool efforts at large universities in order to be able to make new research breakthroughs.
  • Actualise KI's initiatives in data-driven research, precision medicine and open science.
  • Improve the opportunities for clinics to research on patients, patient data and in the laboratory; and raise the status of KI's excellent research in caring sciences and prevention.
  • In light of our ambitious initiatives in data-driven research and precision medicine, the Vice President needs to ensure that KI's basic research - one of our flagships – is allowed to proceed unimpeded!

I enjoy my new role as Vice President for Research, but I feel humbled by both the ongoing electoral process and the confidence shown in me. If I am given continued confidence, I will devote all of my energy to KI - a world-leading university with great potential for improvement.

Christian Giske. Photo: Stefan Zimmerman.
Christian Giske. professor vid institutionen för laboratoriemedicin Foto: Stefan Zimmerman

Christian Giske, Professor at LabMed

About me:

I am a qualified doctor in Trondheim, Norway, and I moved to Stockholm after my internship. At Karolinska University Hospital, I specialized in clinical bacteriology, at the same time as I finished my dissertation on antibiotic resistance on pseudomonas aeruginosa in 2007. I became an associate professor in 2010 and became a research group leader at the Department of Microbiology, Tumor and Cell Biology (MTC) in 2012. Three years later, I moved to the Department of Laboratory Medicine, where I received a lectureship in clinical bacteriology, combined with a position as chief physician at Karolinska University Hospital (KU). Since 2018, I have been a professor on the same department, and I have also been employed as chief physician with management responsibilities in bacteriology at the hospital. For the past two years, I have been head of the Divisions for Clinical Microbiology and Clinical Immunology at the Department of Laboratory Medicine. My research group studies antibiotic resistance and works largely with studies of resistance development to new antibiotics as well as new precision medicine strategies such as bacteriophage therapy. In recent years, I have been one of KI's most-cited researchers.

Christian Giske's profile page.

Visions for my assignment:

Throughout my career, I have maintained close contact with the hospital and I am well established in the hospital's organization, where I have several management assignments (clinic management, R&D management at Medical Diagnostics Karolinska, vice chairman of the hospital's expert review group). My contact network within the hospital (both Flemingsberg and Solna) is of great importance for achieving better collaboration between KI and Karolinska Hospital. I have a great interest in academic leadership and I wish to change certain things at KI. The most important thing is to address the institutions' difficult financial position, by ensuring that a larger part of the appropriations that come to KI find their way out to the departments. My objective is that Karolinska Institutet will, to a lesser extent, be perceived as a research hotel and that we should be more clear in the message we convey to politicians that more money needs to be invested in KI, compared with today's large investments in small colleges/universities. I wish to see continued investments in precision medicine and global health.

Catharina Larsson, Professor at OnkPat. Photo: Erika Rindsjö

Catharina Larsson, Professor at OnkPat

About me:

After the basic education in medicine, I had the opportunity to perform a PhD thesis on tumor-suppressor genes - a new and exciting field that has today reached clinical application. In 1993, the own research group in medical genetics was started, which today consists of collaborative research teams in experimental translational cancer research. More than fifty PhD students who have completed their theses have been supervised (as main or assistant supervisor) and most previous doctoral students and postdocs are today found in academia and healthcare as for example professor, docent and with maintained research and educational activities. I have been awarded the Göran Gustafsson Prize in Medicine and am a member of the Nobel Assembly.

I have good experience from scientific leadership and evaluation nationally and internationally. Previous management assignments include member of the Board of Research (now KF), Board (Konsistoriet), and the Recruitment Committee (Rekryteringsutskottet) at KI; Karolinska University Hospital research and education (FoUU) committee; and the Scientific Council for Medicine and Health at the Swedish Research Council. Today I am Assistant Chair of the Department of Oncology-Pathology with responsibility for higher teaching positions, KI Chairman of the Research & Educational Development group at Medical unit Clinical Pathology and Cancer diagnostics at Karolinska University Hospital, and Member of the Committee for Doctoral Education (KFU).

Catharina Larsson's profile page.

Visions for the assignment:

  • Research at KI shall be a quality sign. This requires continuous development of the research environment, support activities, networks, good finances and basic resources.
  • Medical research is best conducted in harmony with the healthcare. Increased interaction with the Stockholm Region is an important task within the already established Research & Development (FoUU) structures for several issues concerning daily research activities and a clear and uniform system for activity-based allocation.
  • KI shall be an attractive university for researchers at different stages of their careers, where everyone takes pride in doing their best. A prerequisite for being able to focus on the important tasks is clarity and planning for regular announcements of academic positions at different levels.
  • Continuous learning give increased opportunities for innovative research. Through the development in the recent years, there are now opportunities to offer existing parts of education in, for example, important new technologies and research fields to a larger part of KI's researchers.